Thyroid hormone levels are associated with metabolic components: a cross-sectional study.


Journal

Croatian medical journal
ISSN: 1332-8166
Titre abrégé: Croat Med J
Pays: Croatia
ID NLM: 9424324

Informations de publication

Date de publication:
05 Jul 2020
Historique:
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 29 8 2020
Statut: ppublish

Résumé

To analyze the association of thyroid function and hormone levels with metabolic syndrome (MetS) and its components. This cross-sectional population-based study involved 2183 Croatian individuals with no history of thyroid disease, hypertension, diabetes, and hyperlipidemia. MetS was diagnosed according to the National Cholesterol Education Program's Adult Treatment Panel III criteria. We found no association between thyroid function groups and the prevalence of MetS and its components. Clinically hypothyroid participants showed significantly higher triceps skinfold measurements than subclinically hypothyroid and euthyroid participants. Furthermore, clinically hypothyroid participants had higher abdominal skinfold thickness than subclinically hypothyroid participants. Otherwise, suprailiac and abdominal skinfold measurements were higher in the subclinically and clinically hyperthyroid group of participants compared with euthyroid and subclinically hypothyroid participants. A strong positive association of thyroid-stimulating hormone (TSH) and strong negative association of free triiodothyronine (fT3) and free thyroxine (fT4) levels with HOMA-IR and cholesterol levels were found. Furthermore, the fT4 level also showed a strong negative association with HDL and triceps skinfold thickness. This study supports the standing that TSH, fT3, and fT4 levels are important variables to determine the association of thyroid function with MetS.

Identifiants

pubmed: 32643339
pmc: PMC7358678

Substances chimiques

Autoantibodies 0
Autoantigens 0
Iron-Binding Proteins 0
Thyroid Hormones 0
Triiodothyronine 06LU7C9H1V
Thyrotropin 9002-71-5
Thyroglobulin 9010-34-8
Cholesterol 97C5T2UQ7J
TPO protein, human EC 1.11.1.7
Iodide Peroxidase EC 1.11.1.8
Thyroxine Q51BO43MG4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-238

Subventions

Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom

Références

BMC Endocr Disord. 2018 May 21;18(1):29
pubmed: 29783969
Front Horm Res. 2018;49:48-66
pubmed: 29895010
Endocr Rev. 2008 Dec;29(7):777-822
pubmed: 18971485
Med Hypotheses. 2002 Dec;59(6):660-6
pubmed: 12445506
Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):408-13
pubmed: 22931855
Horm Metab Res. 2017 Mar;49(3):192-200
pubmed: 28351085
Clin Chem Lab Med. 2012 Jan 19;50(4):663-6
pubmed: 22505557
Clin Endocrinol (Oxf). 2018 May;88(5):735-743
pubmed: 29453818
Eur J Epidemiol. 2012 May;27(5):379-84
pubmed: 22392590
J Clin Endocrinol Metab. 2007 Feb;92(2):491-6
pubmed: 17090642
Thyroid. 2014 Nov;24(11):1566-74
pubmed: 25069017
BMC Endocr Disord. 2017 Oct 16;17(1):65
pubmed: 29037214
Maturitas. 2009 Mar 20;62(3):301-5
pubmed: 19250778
Acta Med Indones. 2010 Jan;42(1):31-5
pubmed: 20305330
Eur J Endocrinol. 2009 May;160(5):785-90
pubmed: 19141606
Korean J Intern Med. 2011 Dec;26(4):432-9
pubmed: 22205844
Korean J Intern Med. 2013 Mar;28(2):180-6
pubmed: 23525791
PLoS One. 2018 Jun 21;13(6):e0199209
pubmed: 29928001
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):636-642
pubmed: 30641781
Croat Med J. 2006 Aug;47(4):601-10
pubmed: 16909458
Endocr J. 2011;58(1):23-30
pubmed: 21135510
Thyroid. 2014 Feb;24(2):223-31
pubmed: 24032604
Hum Biol. 2008 Oct;80(5):513-33
pubmed: 19341321
Eur J Endocrinol. 2010 Oct;163(4):625-30
pubmed: 20643758
BMJ Open. 2018 Oct 25;8(10):e022974
pubmed: 30366915
Metab Syndr Relat Disord. 2015 Oct;13(8):362-9
pubmed: 26177236
Endocr Rev. 2008 Feb;29(1):76-131
pubmed: 17991805
Metabolism. 2003 Dec;52(12):1542-6
pubmed: 14669152
Eur J Endocrinol. 2003 Oct;149(4):257-71
pubmed: 14514340
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Croat Med J. 2009 Feb;50(1):4-6
pubmed: 19260138
Eur J Endocrinol. 2010 Aug;163(2):273-8
pubmed: 20516204
Clin Endocrinol (Oxf). 2018 Sep;89(3):367-375
pubmed: 29893010

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH